| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |